Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

69
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69
Cancer Prevention02:59

Cancer Prevention

6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

65
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
65
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

173
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
173
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

42
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
42

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.

Circulation·2021
Same author

Periodontal Disease, Atrial Fibrillation and Stroke.

American heart journal·2021
Same author

Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) Study.

Journal of clinical gastroenterology·2021
Same author

Sphingolipids and physical function in the Atherosclerosis Risk in Communities (ARIC) study.

Scientific reports·2021
Same author

Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals.

JAMA network open·2021
Same author

Corrigendum to 'Association of sickle cell trait with measures of cognitive function and dementia in African Americans' <i>eNeurologicalSci,</i> Vol. 16 (2019), 100,201.

eNeurologicalSci·2020

相关实验视频

Updated: Sep 18, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K

癌症和心房动之间的关联:社区中的动脉样硬化风险研究

Romil R Parikh1,2, Chetan Shenoy2, Jeffrey R Misialek1

  • 1Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN.

Mayo Clinic proceedings. Innovations, quality & outcomes
|June 26, 2025
PubMed
概括

癌症诊断显著增加了心房动 (AF) 的风险,特别是在3个月内. 在最初,AF诊断也会增加癌症风险,但随着时间的推移,这种影响会减弱,这表明检测偏差.

更多相关视频

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.8K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.9K

相关实验视频

Last Updated: Sep 18, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.8K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.9K

科学领域:

  • 心血管医学 心血管医学
  • 在瘤学瘤学.
  • 流行病学 流行病学

背景情况:

  • 心房动 (AF) 和癌症是严重的健康问题.
  • 了解AF和癌症之间的时间关系对于患者管理至关重要.
  • 现有的研究尚未完全阐明这些条件之间的双向时间关联.

研究的目的:

  • 调查癌症诊断和随后发生的心房动 (AF) 之间的时间关联.
  • 检查AF诊断和随后发生的癌症之间的时间关联.
  • 在特定的时间框架内分析这些关联:在诊断后3个月内,3至12个月,以及超过12个月.

主要方法:

  • 在社区动脉样硬化风险研究中利用了来自13748名社区成年人的数据.
  • 通过心电图和健康记录确定AF;通过国家注册和健康记录确定癌症.
  • 使用考克斯回归分析,调整共享风险因素和心血管疾病,以估计危险比率.

主要成果:

  • 癌症诊断后出现明显升高的AF风险,在3个月内达到峰值 (HR,11.71) 并保持长期显著.
  • 在AF诊断之后,癌症风险增加,在3个月内最强 (HR,2.24),随着时间的推移减弱.
  • 在所有评估的时间间隔中观察到显著的关联,尽管大小各不相同.

结论:

  • 癌症患者面临着显著增加的AF风险,特别是在诊断后的最初几个月.
  • 患有AF的人在AF诊断后不久就会出现癌症诊断的风险增加.
  • 这些发现表明了潜在的检测偏差和反向因果关系,特别是在AF后的癌症风险方面.